CCR5 provides a signal for microbial induced production of IL-12 by CD8α+ dendritic cells

Nature Immunology

Volumn 1, Issue 1, 2000, Pages 83-87

  Aliberti, Julio ^a   Reis E Sousa, Caetano ^b   Schito, Marco ^a   Hieny, Sara ^a   Wells, Timothy ^c   Huffnagle, Gary B ^d   Sher, Alan ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

^c SERONO PHARMACEUTICAL RES INSTITUTE   (Switzerland)

^d UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD8 ANTIGEN; CHEMOKINE RECEPTOR CCR5; INTERLEUKIN 12; PARASITE ANTIGEN;

ANIMAL; ARTICLE; CELLULAR IMMUNITY; DENDRITIC CELL; IMMUNOLOGY; MOUSE; SIGNAL TRANSDUCTION; TOXOPLASMA; TOXOPLASMOSIS;

ANIMALS; ANTIGENS, CD8; ANTIGENS, PROTOZOAN; DENDRITIC CELLS; IMMUNITY, CELLULAR; INTERLEUKIN-12; MICE; RECEPTORS, CCR5; SIGNAL TRANSDUCTION; TOXOPLASMA; TOXOPLASMOSIS;

EID: 0034231216     PISSN: 15292908     EISSN: None     Source Type: Journal    
DOI: 10.1038/76957     Document Type: Article

References (26)

1. Banchereau, J. & Steinman, R.M. Dendritic cells and the control of immunity. Nature 392, 245-252 (1998).
2. Reis e Sousa, C., Sher, A. & Kaye, P. The role of dendritic cells in the induction and regulation of immunity to microbial infection. Curr. Opin. Immunol. 11, 392-399 (1999).
3. Trinchieri, G. Interleukin-12: a cytokine at the interface of inflammation and immunity. Adv. Immunol. 70, 83-243 (1998).
4. Reis e Sousa, C. et al. In vivo microbial stimulation induces rapid CD40 ligand-independent production of interleukin 12 by dendritic cells and their redistribution to T cell areas. J. Exp. Med. 186, 1819-1829 (1997).
5. Reis e Sousa, C. et al. Paralysis of dendritic cell IL-12 production by microbial products prevents infection-induced immunopathology. Immunity 11, 637-647 (1999).
6. Denkers, E.Y. & Gazzinelli, R.T. Regulation and function of T-cell-mediated immunity during Toxoplasma gondii infection. Clin. Microbiol. Rev. 11, 569-588 (1998).
7. Yap, G.S. & Sher, A. Cell-mediated immunity to Toxoplasma gondii: initiation, regulation and effector function. Immunobiology 201, 240-247 (1999).
8. Sher, A. & Reis e Sousa, C. Ignition of the type 1 response to intracellular infection by dendritic cell-derived interleukin-12. Eur. Cytokine Network 9, 65-68 (1998).
9. Granelli-Piperno, A. et al. Efficient interaction of HIV-1 with purified dendritic cells via multiple chemokine coreceptors. J. Exp. Med. 184, 2433-2438 (1996).
10. Sozzani, S. et al. Receptor expression and responsiveness of human dendritic cells to a defined set of CC and CXC chemokines. J. Immunol. 159, 1993-2000 (1997).
11. Proudfoot, A.E. et al. Extension of recombinant human RANTES by the retention of the initiating methionine produces a potent antagonist. J. Biol. Chem. 271, 2599-2603 (1996).
12. Alfano, M., Schmidtmayerova, H., Amella, C.A., Pushkarsky, T. & Bukrinsky, M. The B-oligomer of pertussis toxin deactivates CC chemokine receptor 5 and blocks entry of M-tropic HIV-1 strains. J. Exp. Med. 190, 597-605 (1999).
13. Scharton-Kersten, T.M., Yap, G., Magram, J. & Sher, A. Inducible nitric oxide is essential for host control of persistent but not acute infection with the intracellular pathogen Toxoplasma gondii. J. Exp. Med. 185, 1261-1273 (1997).
14. Fahey, T.J.D. et al. Macrophage inflammatory protein 1 modulates macrophage function. J. Immunol. 148, 2764-2769 (1992).
15. Lukacs, N.W. et al. C-C chemokines differentially alter interleukin-4 production from lymphocytes. Am. J. Pathol. 150, 1861-1868 (1997).
16. Alkhatib, G. et al. CC CKR5: a RANTES, MIP-1α, MIP-1β receptor as a fusion cofactor for macrophage-tropic HIV-1. Science 272, 1955-1958 (1996).
17. Berger, E.A., Murphy, P.M. & Farber, J.M. Chemokine receptors as HIV-1 coreceptors: roles in viral entry, tropism, and disease. Annu. Rev. Immunol. 17, 657-700 (1999).
18. Meyer, L. et al. CCR5 delta32 deletion and reduced risk of toxoplasmosis in persons infected with human immunodeficiency virus type 1. The SEROCO-HEMOCO-SEROGEST Study Groups. J. Infect. Dis. 180, 920-924 (1999).
19. Huffnagle, G.B. et al. Cutting edge: Role of C-C chemokine receptor 5 in organ-specific and innate immunity to Cryptococcus neoformans. J. Immunol. 163, 4642-4646 (1999).
20. Zhou, Y. et al. Impaired macrophage function and enhanced T cell-dependent immune response in mice lacking CCR5, the mouse homologue of the major HIV-1 coreceptor. J. Immunol. 160, 4018-4025 (1998).
21. Sato, N. et al. Defects in the generation of IFN-γ are overcome to control infection with Leishmania donovani in CC chemokine receptor (CCR) 5-, macrophage inflammatory protein-1 alpha-, or CCR2-deficient mice. J. Immunol. 163, 5519-5525 (1999).
22. Braun, M.C., Lahey, E. & Kelsall, B.L. Selective suppression of IL-12 production by chemoattractants. J. Immunol. 164, 3009-3017 (2000).
23. He, J., Gurimathan, S., Ash-Shaheed, B. & Kelsall, B. Primary role for Gi protein signaling in the regulation of interleukin 12 production and the induction of T helper cell type 1 responses. J. Exp. Med. 191, 1605-1610 (2000).
24. Bonecchi, R. et al. Differential expression of chemokine receptors and chemotactic responsiveness of type 1 T helper cells (Th1s) and Th2s. J. Exp. Med. 187, 129-134 (1998).
25. Grunvald, E. et al. Biochemical characterization and protein kinase C dependency of monokine-inducing activities of Toxoplasma gondii. Infect. Immun. 64, 2010-2018 (1996).
26. Scharton-Kersten, T. M. et al. In the absence of endogenous IFN-γ, mice develop unimpaired IL-12 responses to Toxoplasma gondii while failing to control acute infection. J. Immunol. 157, 4045-4054 (1996).